SCHEMBL6683199

SCHEMBL6683199

CCOC(=O)c1cccc(C=C2C=C(c3cccc(OC)c3)C(CN(C)C)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.49
CCR6 P51684 2/20 0.49
MAPT P10636 3/20 0.40
ALDH1A1 P00352 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
KDM4E B2RXH2 2/20 0.36
TP53 P04637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CACNB4 O00305 1/20 0.35
CACNA1A O00555 1/20 0.35
CACNA1G O43497 1/20 0.35
CACNG3 O60359 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6683197 1.00 HSP90AA1 (0.49) HSP90AA1CCR6MAPTALDH1A1SMN1; SMN2
SCHEMBL6678567 0.92 HSP90AA1 (0.47) HSP90AA1CCR6MAPTALDH1A1SMN1; SMN2
SCHEMBL6678563 0.92 HSP90AA1 (0.47) HSP90AA1CCR6MAPTALDH1A1SMN1; SMN2
SCHEMBL6677969 0.90 HSP90AA1 (0.52) HSP90AA1CCR6ALDH1A1NPC1RAB9A
SCHEMBL6680149 0.90 HSP90AA1 (0.52) HSP90AA1CCR6ALDH1A1NPC1RAB9A
SCHEMBL6680155 0.90 HSP90AA1 (0.52) HSP90AA1CCR6ALDH1A1NPC1RAB9A
SCHEMBL6684147 0.90 HSP90AA1 (0.48) HSP90AA1CCR6ALDH1A1MEN1KMT2A
SCHEMBL6684139 0.90 HSP90AA1 (0.48) HSP90AA1CCR6ALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL6716591 0.90 HSP90AA1 (0.53) HSP90AA1CCR6ALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL6716594 0.90 HSP90AA1 (0.53) HSP90AA1CCR6ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246793-B1 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2004-11-10 EP claimed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US claimed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US claimed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US disclosed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives PTGER1, CYP2E1, HRH2 HSP90AA1 1652/4885CCR6 1317/4885MAPT 953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.